The International Space Station (ISS) is a closed ecosystem, and the biology inside it — including its microbial residents — ...
Armata Pharmaceuticals, Inc. ("Armata" or the "Company"), a late clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the ...
FDA agreed that data from the Phase 2a diSArm study support advancement of AP-SA02 to a Phase 3study First bacteriophage company to advance a clinical candidate to ...
In a new study, terrestrial bacteria-infecting viruses were still able to infect their E. coli hosts in near-weightless ...
A research team at the Medical University of Vienna has discovered a new approach to treating a particularly frequent and ...
Psilocybin-assisted therapy is legal in three states, but access has so far been limited and expensive. In the billion-dollar race to commercialize psychedelic medicine, psilocybin, a naturally ...
Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita ...
But, under anti-vaccine Health Secretary Robert F. Kennedy Jr.—who has numerous ties to the wellness industry—that FDA ...
The twisting journey of Pretzel Therapeutics’ top brass appears to have come full circle, with the biotech subsuming the very ...
Antibiotic resistance is a worsening global crisis, and livestock production plays a key role. Indiscriminate antibiotic use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback